[1]罗亚丽,黄志刚,罗思通,等.妊娠期肝内胆汁淤积症孕妇血清PDCD4，GLUT1 表达水平及其与妊娠结局的相关性研究[J].现代检验医学杂志,2023,38(03):143-148.[doi:10.3969/j.issn.1671-7414.2023.03.026]
　LUO Ya-li,HUANG Zhi-gang,LUO Si-tong,et al.Study on the Expression Level of Serum PDCD4 and GLUT1 in Pregnant Women with Intrahepatic Cholestasis During Pregnancy and Its Correlation with Pregnancy Outcome[J].Journal of Modern Laboratory Medicine,2023,38(03):143-148.[doi:10.3969/j.issn.1671-7414.2023.03.026]
点击复制

妊娠期肝内胆汁淤积症孕妇血清PDCD4，GLUT1 表达水平及其与妊娠结局的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年03期
页码:
143-148
栏目:
论著
出版日期:
2023-05-15

文章信息/Info

Title:
Study on the Expression Level of Serum PDCD4 and GLUT1 in Pregnant Women with Intrahepatic Cholestasis During Pregnancy and Its Correlation with Pregnancy Outcome
文章编号:
1671-7414（2023）03-143-06
作者:
罗亚丽1; 黄志刚2; 罗思通1; 徐 洲3
（1. 巴中市巴州区妇幼保健院妇产科，四川巴中 636000；2. 四川大学华西医院实验医学科，成都 610041；3. 四川锦欣妇女儿童医院妇产科，成都 610066）
Author(s):
LUO Ya-li1;  HUANG Zhi-gang2;  LUO Si-tong1;  XU Zhou3
（1. Department of Obstetrics and Gynecology ，Bazhong City Bazhou District Maternal and Child Health Hospital, Sichuan Bazhong 636000，China; 2. Department of Experimental Medicine，West China Hospital, Sichuan University, Chengdu 610041, China; 3. Departmen
关键词:
妊娠期肝内胆汁淤积症; 程序性细胞死亡因子4; 葡萄糖转运蛋白1
分类号:
R714.255；R446.11
DOI:
10.3969/j.issn.1671-7414.2023.03.026
文献标志码:
A
摘要:
目的 检测妊娠期肝内胆汁淤积症（intrahepatic cholestasis of pregnancy，ICP）孕妇血清程序性细胞死亡因子4（programmed cell death factor 4，PDCD4）和葡萄糖转运蛋白1（glucose transporter 1，GLUT1）的表达水平，分析二者与孕妇妊娠结局的相关性。方法 收集巴中市巴州区妇幼保健院产科2018 年7 月～ 2020 年7 月收治的ICP 孕妇126 例作为研究组，其中轻度ICP 组46 例，重度ICP 组80 例，选择同期该院120 例健康产检孕妇作为对照组。采用实时荧光定量PCR（qRT-PCR）法测定ICP 孕妇血清PDCD4 和GLUT1 水平，多因素Logistic 回归分析影响ICP 孕妇妊娠结局的因素，Pearson 相关性分析ICP 孕妇血清PDCD4 和GLUT1 水平的相关性。结果 与对照组比较，研究组PDCD4（1.36±0.23 vs 1.02±0.21），GLUT1（1.40±0.22 vs 0.99±0.18）水平升高，差异具有统计学意义（t=15.935，12.090，均P=0.000）。重度ICP 组PDCD4（1.41±0.25），GLUT1（1.45±0.22）水平显著高于轻度ICP 组（1.27±0.20，1.31±0.21），差异具有统计学意义（t=3.246，3.496，均P ＜ 0.05）。研究组羊水胎粪污染（20.63%）、自发性早产（7.14%）、产后出血（8.73%）、宫内窘迫（11.90%）等不良妊娠结局的发生率均高于对照组（0.00%，0.83%，0.83%，1.67%），差异均具有统计学意义（χ2=1.049 ～ 29.159，均P ＜ 0.05）；妊娠结局良好组和妊娠结局不良组患者的发病程度（OR=1.109，95% CI =1.035 ～ 1.188）、 PDCD4（OR=1.428，95% CI =1.013 ～ 2.012）以及GLUT1（OR=1.453，95%CI =1.066 ～ 1.980）水平差异具有统计学意义（均P ＜ 0.05）；多因素Logistic 回归分析显示，发病程度、PDCD4，GLUT1 为ICP 孕妇妊娠结局不良的影响因素（Waldχ2==8.738，1.428，1.453；P=0.003，0.041，0.018）；Pearson 相关性分析显示，ICP 孕妇血清PDCD4 与GLUT1 水平呈正相关（r=0.460，P ＜ 0.05）。结论 PDCD4，GLUT1 在ICP 孕妇血清中表达均上调，二者呈正相关，是ICP 孕妇妊娠结局不良的影响因素。
Abstract:
Objective To measure the expression levels of serum programmed cell death 4 (PDCD4) and glucose transporter 1 (GLUT1) in pregnant women with intrahepatic cholestasis of pregnancy (ICP), and analyze the correlation between the two and the pregnancy outcome of pregnant women. Methods From July 2018 to July 2020, 126 pregnant women with ICP who were admitted to Department of Obstetrics and Gynecology，Bazhong City Bazhou District Maternal and Child Health Hospital were gathered as the study group, including 46 cases in mild ICP group and 80 cases in severe ICP group. A total of 120 healthy pregnant women in the hospital were regarded as the control group. Quantitative real-time PCR (qRT-PCR) was used to measure the serum PDCD4 and GLUT1 levels in pregnant women with ICP, multivariate logistic regression was performed to analyze the factors affecting pregnancy outcomes in pregnant women with ICP, and Pearson correlation was performed to analyze the correlation of serum PDCD4 and GLUT1 levels in pregnant women with ICP. Results The levels of PDCD4(1.36±0.23 vs 1.02±0.21) and GLUT1(1.40±0.22 vs 0.99±0.18) in the study group were obviously higher than those in the control group (t=15.935,12.090，all P=0.000).The levels of PDCD4(1.41±0.25)and GLUT1(1.45±0.22)in the severe ICP group were obviously higher than those in the mild ICP group（1.27±0.20，1.31±0.21）, the differences were statistically significant （t=3.246，3.496，all P ＜ 0.05）. The incidences of adverse pregnancy outcomes such as amniotic fluid meconium pollution(20.63%), spontaneous premature birth(7.14%), postpartum hemorrhage(8.73%), and intrauterine distress(11.90%) in the study group were higher than those in the control group（0.00%，0.83%，0.83%，1.67%）, and the differences were statistically significant（χ2=1.049 ～ 29.159，all P ＜ 0.05）, and there were significant differences in the incidence (OR=1.109, 95% CI =1.035 ～ 1.188), PDCD4 (OR=1.428, 95% CI =1.013 ～ 0.012) and GLUT1 (OR=1.453, 95% CI =1.066 ～ 1.980) levels between the two groups ( all P<0.05). Multivariate Logistic regression analysis showed that the severity of disease,PDCD4 and GLUT1 were the influencing factors of poor pregnancy outcomes in pregnant women with ICP (χ2=8.738,1.428,1.453, P=0.003,0.041,0.018). The results of Pearson correlation analysis showed that the serum PDCD4 and GLUT1 levels of pregnant women with ICP were positively correlated (r=0.460, P<0.05).Conclusion The expressions of PDCD4 and GLUT1 in the serum of pregnant women with ICP were both up-regulated, and the two were positively correlated. They are the influencing factors of poor pregnancy outcomes of pregnant women with ICP.

参考文献/References:

[1] 刘莉娜, 武伟琦. 妊娠期肝内胆汁淤积症孕妇临床 特点及妊娠结局分析[J]. 中国临床新医学, 2017,10(7): 668-671. LIU Lina, WU Weiqi. Clinical analysis of 135 pregnant women with intrahepatic cholestasis during pregnancy and their pregnant outcomes[J]. Chinese Journal of New Clinical Medicine, 2017, 10(7): 668-671.
[2] 李阳芳, 程群仙, 李航, 等. 妊娠期肝内胆汁淤积症 孕妇总胆汁酸水平与妊娠不良结局研究[J]. 肝脏,2019, 24(7): 817-818. LI Yangfang, CHENG Qunxian, LI Hang, et al. Study on the level of total bile acid and adverse pregnancy outcome in pregnant women with intrahepatic cholestasis during pregnancy[J]. Chinese Hepatology,2019, 24(7): 817-818.
[3] 胡翠芳, 朱大伟, 李力. 妊娠期肝内胆汁淤积症的研 究进展[J]. 中国实用妇科与产科杂志, 2021, 37(2): 248-252. HU Cuifang, ZHU Dawei, LI Li. Research progress of intrahepatic cholestasis during pregnancy[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2021,37(2): 248-252.
[4] 武建利, 李玲, 李芳. 妊娠期肝内胆汁淤积症孕妇胎 儿血清胆汁酸水平对妊娠结局的影响[J]. 新疆医学,2015, 45(12): 1749-1751. WU Jianli, LI Ling, LI Fang. Influence of bile acid levels in fetus and pregnant woman undergoing intrahepatic cholestasis on pregnancy outcomes[J]. Xinjiang Medical Journal, 2015, 45(12): 1749-1751.
[5] ZHANG Jiandong, MA Lei, SHI Daimeng, et al. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection[J]. Journal of Cellular Biochemistry,2018, 119(6): 4783-4791.
[6] 巴赫, 彭强, 朱耀东. 胃癌组织中PDCD4 基因的表 达和甲基化水平及其临床意义[J]. 肿瘤防治研究,2020, 47(12): 942-946. BA He, PENG Qiang, ZHU Yaodong. Expression and methylation of PDCD4 in gastric carcinoma and its clinical significance[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 942-946.
[7] XIA Huanjun, ZHAO Yaxian. MiR-155 is highexpressed in polycystic ovarian syndrome and promotes cell proliferation and migration through targeting PDCD4 in KGN cells[J]. Artificial Cells,Nanomedicine, and Biotechnology (Print), 2020, 48(1): 197-205.
[8] ACOSTA O, RAMIREZ V I, LAGER S, et al. Increased glucose and placental GLUT-1 in large infants of obese nondiabetic mothers[J]. American Journal of Obstetrics and Gynecology, 2015, 212(2): 227,e1-7.
[9] 中华医学会妇产科学分会产科学组. 妊娠期肝内 胆汁淤积症诊疗指南(2015）[J]. 中华妇产科杂志,2015(7): 481-485. Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy (2015)[J]. Chinese Journal of Obstetrics and Gynecology, 2015(7): 481-485.
[10] 胡绪林, 陈妍, 夏红萍, 等. 不同程度小于胎龄儿的 母体临床危险因素分析[J]. 上海交通大学学报( 医 学版), 2020, 40(4): 489-493. HU Xulin, CHEN Yan, XIA Hongping, et al. Analysis of maternal clinical risk factors for different degrees of small for gestational age infant[J]. Journal of Shanghai Jiaotong University(Medical Science), 2020, 40(4): 489-493.
[11] 万彦婷, 李芳, 洪燕, 等. 174 例妊娠期肝内胆汁淤 积症孕妇母儿结局临床分析[J]. 江西中医药大学学 报, 2020, 32(5): 39-42. WAN Yanting, LI Fang, HONG Yan, et al. Clinical analysis of maternal and fetal outcomes in 174 pregnant women with intrahepatic cholestasis of pregnancy[J]. Journal of Jiangxi University of Traditional Chinese Medicine, 2020, 32(5): 39-42.
[12] 郭金珠, 谭长安. ICP 孕妇血流动力学与炎性因子 及妊娠结局的变化研究[J]. 长春中医药大学学报,2020, 36(6): 1249-1251. GUO J i n z h u , TAN Chang’ an. Change s o f hemodynamics and inflammatory factors in pregnant women with ICP and pregnancy outcome[J]. Journal of Changchun University of Traditional Chinese Medicine,2020, 36(6): 1249-1251.
[13] 朱文芳, 韩双, 邹爱民, 等. 血清TBA 和CG 检测 在妊娠期肝内胆汁淤积症早期诊断及围产儿不良 结局影响的临床意义[J]. 现代检验医学杂志, 2017,32(6): 112-114. ZHU Wenfang, HAN Shuang, ZOU Aimin, et al. Clinical significance of detecting serum TBA and CG in early diagnosis of intrahepatic cholestasis of pregnancy and perinatal adverse outcomes influence[J]. Journal of Modern Laboratory Medicine, 2017, 32(6): 112-114.
[14] 王彤, 曾观银, 徐凤丹, 等. 血清游离胆汁酸CA,LCA 及胎盘HIF-1α 表达水平与ICP 患者不良妊 娠结局的相关性研究[J]. 现代检验医学杂志, 2022,37(1): 52-55, 71. WANG Tong, ZENG Guanyin, XU Fengdan, et al. Correlation between serum free bile acid CA,LCA and placental HIF-1αexpression levels and adverse Pregnancy outcomes in patients with ICP[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 52-55, 71.
[15] OVADIA C, SEED P T, SKLAVOUNOS A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses[J]. The Lancet, 2019, 393(10174): 899-909.
[16] 王之萍, 杜洁. 妊娠期肝内胆汁淤积症产妇血清胆 汁酸、ALT, AST 水平变化及对围生儿的影响[J]. 山 东医药, 2015, 55(2): 48-49. WANG Zhiping, DU Jie. Changes of serum TBA, ALT and AST levels in pregnant women with intrahepatic cholestasis during pregnancy and their effects on perinatal infants[J]. Shandong Medical Journal, 2015,55(2): 48-49.
[17] HAO Yajuan, HUANG Jiawei, MA Yun, et al. Asiatic acid inhibits proliferation, migration and induces apoptosis by regulating PDCD4 via the PI3K/Akt/ mTOR/p70S6K signaling pathway in human colon carcinoma cells[J]. Oncology Letters, 2018, 15(6): 8223-8230.
[18] CHAIWANGYEN W, OSPINA-PRIETO S, PHOTINI S M, et al. Dissimilar microRNA-21 functions and targets in trophoblastic cell lines of different origin[J]. The International Journal of Biochemistry & Cell Biology, 2015, 68(1): 187-196.
[19] FENG Fan, LEI Lei, LIAO Junqun, et al. Circ_0060731 mediated miR-21-5p-PDCD4/ESR1 pathway to induce apoptosis of placental trophoblasts in intrahepatic cholestasis of pregnancy[J]. Tissue & Cell, 2022, 76: 101771.
[20] ILLSLEY N P. Glucose transporters in the human placenta[J]. Placenta, 2000, 21(1): 14-22.
[21] BAUMANN M U, ZAMUDIO S, ILLSLEY N P. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1[J]. American Journal of Physiology. Cell Physiology, 2007, 293(1): C477-C485.
[22] 景晓琳, 邢爱耘, 白怀, 等. miRNA-148b-3p 调节胎 盘滋养细胞GLUT1 表达与ICP 子代糖代谢紊乱关 系的研究[J]. 四川大学学报( 医学版), 2019, 50(3): 328-333. JING Xiaolin, XING Aiyun, BAI Huai, et al. MiRNA- 148b-3p influences glucose metabolism of offspring with maternal cholestasis by regulating GLUT1 expression in placental trophoblast cells[J]. Journal of Sichuan University (Medical Sciences), 2019, 50(3): 328-333.
[23] 陈昀, 邢爱耘, 胡雅毅. 糖酵解相关基因在妊娠期肝 内胆汁淤积症患者胎盘组织内的变化[J]. 中华妇幼 临床医学杂志( 电子版), 2017, 13(1): 71-77. CHEN Yun, XING Aiyun, HU Yayi. Changes of glycometabolic genes in placenta of intrahepatic cholestasis of pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2017, 13(1): 71-77.
[24] 苏瑞芬, 吴小莉, 柯凤梅. 子痫前期患者胎盘组织 miR-373，PDCD4 表达与胎盘螺旋动脉重铸的关系 [J]. 中国性科学, 2021, 30(12): 94-97. SU Ruifen, WU Xiaoli, KE Fengmei. The relationship between the expression of miR-373 and PDCD4 in placental tissues of preeclampsia and placental spiral artery remodeling[J]. Chinese Journal of Human Sexuality, 2021, 30(12): 94-97.

相似文献/References:

[1]朱文芳,韩 双,邹爱民,等.血清TBA,CG检测在妊娠期肝内胆汁淤积症早期诊断及围产儿不良结局影响的临床意义[J].现代检验医学杂志,2017,32(06):112.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　ZHU Wen-fang,HAN Shuang,ZOU Ai-min,et al.Clinical Significance of Detecting Serum TBA and CG in Early Diagnosis of Intrahepatic Cholestasis of Pregnancy and Perinatal Adverse Outcomes Influence[J].Journal of Modern Laboratory Medicine,2017,32(03):112.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[2]朱 婷,吕艳关.妊娠期肝内胆汁淤积症患者血清肝胆酸、总胆汁酸水平及血浆凝血功能检测的临床诊断意义[J].现代检验医学杂志,2019,34(04):79.[doi:10.3969/j.issn.1671-7414.2019.04.019]
　ZHU Ting,L(¨overU)Yan-guan.Clinical Significance of Serum Hepatocholic Acid, Total Bile Acid Level and Plasma Coagulation Function Test in Patients with Intrahepatic Cholestasis During Pregnancy[J].Journal of Modern Laboratory Medicine,2019,34(03):79.[doi:10.3969/j.issn.1671-7414.2019.04.019]
[3]汪学耀,张涛,荆成宝.血清总胆汁酸与甘胆酸水平诊断妊娠期肝内胆汁淤积症能力的Meta 分析[J].现代检验医学杂志,2020,35(05):73.[doi:10.3969/j.issn.1671-7414.2020.05.019]
　WANG Xue-yao,ZHANG Tao,JING Cheng-bao.Meta Analysis of the Ability of Total Bile Acid and Cholyglycine to Diagnose Intrahepatic Cholestasis of Pregnancy[J].Journal of Modern Laboratory Medicine,2020,35(03):73.[doi:10.3969/j.issn.1671-7414.2020.05.019]
[4]饶向东,刘振宇,汤红亮,等.胃癌患者血清miR-181b和PDCD4水平表达与幽门螺杆菌感染的关系[J].现代检验医学杂志,2021,36(04):1.[doi:10.3969/j.issn.1671-7414.2021.04.001]
　RAO Xiang-dong,LIU Zhen-yu,TANG Hong-liang,et al.Relationship between the Expression of miR-181b, PDCD4 and Helicobacter Pylori Infection in Patients with Gastric Cancer[J].Journal of Modern Laboratory Medicine,2021,36(03):1.[doi:10.3969/j.issn.1671-7414.2021.04.001]
[5]杜龙庭,勿坡巫且,许春梅,等.缺血性脑卒中患者血清miR-155和PDCD4mRNA表达水平与颈动脉支架成形术后再狭窄的相关性研究[J].现代检验医学杂志,2022,37(02):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
　DU Long-ting,WUPO Wu-qie,XU Chun-mei,et al.Correlation between the Expression of miR-155, PDCD4 mRNA and Restenosis after Carotid Artery Stenting in Patients with Cerebral Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2022,37(03):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]

备注/Memo

备注/Memo:
基金项目：四川省医学会青年创新科研课题计划（S21092）：经方“麻黄连翘赤小豆- 茵陈篙汤”治疗妊娠期肝内胆汁淤积症的临床研究。
作者简介：罗亚丽（1982-），女，本科，副主任医师，研究方向：妊娠期内分泌疾病的诊疗，E-mail：luo_yali1982@163.com。
通讯作者：徐洲（1978-），男，硕士，主任医师，研究方向：辅助生殖妊娠，E-mail：kjkhk98@163.com。
更新日期/Last Update: 2023-05-15